Table 5 Associations of staging of hypertensive retinopathy using optical coherence tomography angiography and other organ damages (n = 154 sujects)a
Variables | N | Cases (%) | Crude OR (95% CI) | P | Ajusted OR (95% CI) | P |
|---|---|---|---|---|---|---|
Renal damage (eGFR<60ml/min/1.73 m2) | ||||||
Controls | 60 | 0 (0.0) | − | − | − | − |
OCTA stage 1 | 17 | 4 (23.5) | 1.0 (1.0, 1.0) | Ref. | 1.0 (1.0, 1.0) | Ref. |
OCTA stage 2 | 42 | 26 (61.9) | 5.3 (1.5, 19.0) | 0.011 | 3.9 (1.0, 15.8) | 0.052 |
OCTA stage 3 | 35 | 25 (71.4) | 8.1 (2.1, 31.0) | 0.002 | 5.6 (1.2, 25.2) | 0.025 |
History of cardiovascular events | ||||||
Controls | 60 | 0 (0.0) | − | − | − | − |
OCTA stage 1 | 17 | 0 (0.0) | − | − | − | − |
OCTA stage 2 | 42 | 3 (7.1) | 1.0 (1.0, 1.0) | Ref. | 1.0 (1.0, 1.0) | Ref. |
OCTA stage 3 | 35 | 3 (8.6) | 1.2 (0.2, 6.5) | 0.816 | 1.3 (0.2, 7.9) | 0.788 |
